| Primary |
| Computerised Tomogram Abdomen |
36.2% |
| Computerised Tomogram |
26.1% |
| Drug Use For Unknown Indication |
15.2% |
| Computerised Tomogram Thorax |
7.1% |
| Premedication |
4.2% |
| Angiogram |
1.9% |
| Urogram |
1.6% |
| Product Used For Unknown Indication |
1.3% |
| Computerised Tomogram Head |
1.2% |
| Scan Brain |
1.2% |
| Abdominal Pain |
0.7% |
| Type 2 Diabetes Mellitus |
0.6% |
| Haematuria |
0.4% |
| Angina Pectoris |
0.4% |
| Pain |
0.3% |
| Abdomen Scan |
0.3% |
| Angiogram Cerebral |
0.3% |
| Cardiac Failure |
0.3% |
| Diabetes Mellitus |
0.3% |
| Positron Emission Tomogram |
0.3% |
|
| Urticaria |
49.2% |
| Vomiting |
10.2% |
| Sneezing |
6.3% |
| Pruritus |
4.0% |
| Throat Irritation |
3.4% |
| Throat Tightness |
2.9% |
| Rash |
2.9% |
| Nausea |
2.8% |
| Contrast Media Reaction |
2.5% |
| Dyspnoea |
2.1% |
| Extravasation |
2.0% |
| Respiratory Arrest |
1.7% |
| Swelling Face |
1.6% |
| Wheezing |
1.5% |
| Urinary Incontinence |
1.3% |
| Adverse Event |
1.2% |
| Hypoaesthesia |
1.2% |
| Tachycardia |
1.2% |
| Anaphylactic Shock |
1.0% |
| Loss Of Consciousness |
1.0% |
|
| Secondary |
| Computerised Tomogram Abdomen |
26.2% |
| Computerised Tomogram |
17.2% |
| Computerised Tomogram Thorax |
13.1% |
| Ovarian Cancer |
4.9% |
| Abdominal Pain |
3.3% |
| Abdominal Pain Lower |
3.3% |
| Appendicitis |
3.3% |
| Drug Use For Unknown Indication |
3.3% |
| Hypertension |
3.3% |
| Renal Cyst |
3.3% |
| Schizoaffective Disorder |
3.3% |
| Angiogram |
2.5% |
| Carcinoid Tumour |
1.6% |
| Chest X-ray Abnormal |
1.6% |
| Computerised Tomogram Head |
1.6% |
| Cough |
1.6% |
| Diarrhoea |
1.6% |
| Dysuria |
1.6% |
| Flank Pain |
1.6% |
| Irritable Bowel Syndrome |
1.6% |
|
| Urticaria |
21.9% |
| Throat Irritation |
12.5% |
| Vomiting |
9.4% |
| Ear Pruritus |
6.3% |
| Sneezing |
6.3% |
| Throat Tightness |
6.3% |
| Cough |
4.7% |
| Pruritus |
4.7% |
| Swelling Face |
4.7% |
| Drug Interaction |
3.1% |
| Dyspnoea |
3.1% |
| Nausea |
3.1% |
| Rash Macular |
3.1% |
| Flushing |
1.6% |
| Localised Oedema |
1.6% |
| Muscle Tightness |
1.6% |
| Rash |
1.6% |
| Shock |
1.6% |
| Sleep Disorder |
1.6% |
| Swelling |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
43.6% |
| Fistulogram |
10.3% |
| Nuclear Magnetic Resonance Imaging |
10.3% |
| Angiogram |
6.8% |
| Hepatic Neoplasm Malignant |
4.0% |
| Anticoagulant Therapy |
2.3% |
| Diabetes Mellitus |
2.3% |
| Nausea |
2.3% |
| Cardiac Stress Test |
1.9% |
| Insomnia |
1.9% |
| Pruritus |
1.9% |
| Urosepsis |
1.9% |
| Pain |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Dermatitis |
1.4% |
| Paronychia |
1.4% |
| Rash |
1.4% |
| Arteriogram Coronary |
1.2% |
| Computerised Tomogram |
1.2% |
| Computerised Tomogram Abdomen |
1.2% |
|
| Nephrogenic Fibrosing Dermopathy |
19.1% |
| Nephrogenic Systemic Fibrosis |
19.1% |
| Upper Gastrointestinal Haemorrhage |
10.6% |
| Skin Tightness |
8.5% |
| Confusional State |
6.4% |
| Off Label Use |
6.4% |
| Skin Induration |
4.3% |
| Uveitis |
4.3% |
| Weight Decreased |
4.3% |
| Dysstasia |
2.1% |
| Pain |
2.1% |
| Skin Swelling |
2.1% |
| Spinal Compression Fracture |
2.1% |
| Swelling |
2.1% |
| Tumour Lysis Syndrome |
2.1% |
| Venous Insufficiency |
2.1% |
| Venous Stasis |
2.1% |
|
